Are you Dr. Kanwar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 42 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
500 Parnassus Ave
Mu4e
San Francisco, CA 94143Phone+1 415-476-5892Fax+1 415-476-1343- Is this information wrong?
Summary
- Dr. Bittoo Kanwar, MD is a pediatric gastroenterologist in San Francisco, California. He is currently licensed to practice medicine in California. He is an Assistant Professor at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Gastroenterology, 2005 - 2009
- Rush University Medical CenterResidency, Pediatrics, 2002 - 2005
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2005 - 2023
Clinical Trials
- A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C Start of enrollment: 2010 Oct 01
- A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C Start of enrollment: 2010 Oct 01
- GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsPTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.William J. Sandborn, Larry C. Mattheakis, Nishit B. Modi, David Pugatch, Brian Bressler, Scott D. Lee, Raj Bhandari, Bittoo Kanwar, Richard Shames, Geert R. D'Haens, S...> ;Gastroenterology. 2021 Dec 1
- 70 citationsSofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection.Stefan Wirth, Philip J. Rosenthal, Regino P. Gonzalez-Peralta, Maureen M. Jonas, William F. Balistreri, Chuan Hao Lin, Winita Hardikar, Kathryn Kersey, Benedetta Masse...> ;Hepatology. 2017 Oct 1
- 123 citationsThe safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.William F. Balistreri, Karen F. Murray, Philip J. Rosenthal, Sanjay Bansal, Chuan Hao Lin, Kathryn Kersey, Benedetta Massetto, Yanni Zhu, Bittoo Kanwar, Polina German,...> ;Hepatology. 2017 Aug 1
- Join now to see all